PubRank

J Belaiche

Author PubWeight™ 104.16‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001 33.12
2 Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut 2001 4.23
3 Does co-treatment with immunosuppressors improve outcome in patients with Crohn's disease treated with adalimumab? Aliment Pharmacol Ther 2012 2.74
4 Genetic analyses of chromosome 12 loci in Crohn's disease. Gut 2000 2.30
5 Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998 2.20
6 Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. Gut 1994 2.03
7 Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's disease. Aliment Pharmacol Ther 2004 1.87
8 A high serum concentration of interleukin-6 is predictive of relapse in quiescent Crohn's disease. Eur J Gastroenterol Hepatol 1997 1.85
9 Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease. Aliment Pharmacol Ther 2004 1.62
10 Early development of stricturing or penetrating pattern in Crohn's disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype. Gut 2003 1.55
11 Association between myelodysplastic syndromes and inflammatory bowel diseases. Report of seven new cases and review of the literature. Leukemia 1997 1.50
12 The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases. Genes Immun 2007 1.50
13 A positive response to infliximab in Crohn disease: association with a higher systemic inflammation before treatment but not with -308 TNF gene polymorphism. Scand J Gastroenterol 2002 1.38
14 Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease. Clin Exp Immunol 2000 1.30
15 Tumor necrosis factor alpha decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: potential regulation of the glucocorticoid receptor. J Clin Endocrinol Metab 1999 1.25
16 Tumour necrosis factor (TNF) gene polymorphism in Crohn's disease (CD): influence on disease behaviour? Clin Exp Immunol 2000 1.06
17 Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn's disease. Am J Gastroenterol 2002 1.03
18 Increased frequency of bronchial hyperresponsiveness in patients with inflammatory bowel disease. Allergy 1995 0.98
19 Profile of soluble cytokine receptors in Crohn's disease. Gut 2005 0.97
20 Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID). Eur J Gastroenterol Hepatol 1996 0.96
21 CARD4/NOD1 is not involved in inflammatory bowel disease. Gut 2003 0.94
22 Acute pancreatitis attributed to the use of interferon alfa-2b. Gastroenterology 2000 0.92
23 Effects of dexamethasone on the profile of cytokine secretion in human whole blood cell cultures. Regul Pept 1998 0.91
24 Insulin secretion, clearance, and action on glucose metabolism in cirrhotic patients. J Clin Endocrinol Metab 1993 0.89
25 Anti-tumor necrosis factor nonresponders in Crohn's disease: therapeutic strategies. Dig Dis 2009 0.89
26 Comparison of budesonide and 5-aminosalicylic acid enemas in active distal ulcerative colitis. Aliment Pharmacol Ther 1995 0.88
27 Circulating gastrin, endocrine cells, histamine content, and histidine decarboxylase activity in atrophic gastritis. Gastroenterology 1989 0.88
28 Clinical pattern of corticosteroid dependent Crohn's disease. Eur J Gastroenterol Hepatol 1998 0.88
29 Deleterious influence of pyrazinamide on the outcome of patients with fulminant or subfulminant liver failure during antituberculous treatment including isoniazid. Hepatology 1995 0.86
30 Clustering of Crohn's disease within affected sibships. Eur J Hum Genet 2003 0.85
31 Increased expression of receptor activator of NF-kappaB ligand (RANKL), its receptor RANK and its decoy receptor osteoprotegerin in the colon of Crohn's disease patients. Clin Exp Immunol 2004 0.85
32 Development of adenocarcinoma in chronic fistula in Crohn's disease. Acta Gastroenterol Belg 2005 0.84
33 [Clinical case of the month. Hepatoportal sclerosis in a patient treated with azathioprine]. Rev Med Liege 1998 0.83
34 Evolution of the prevalence and characteristics of anemia in inflammatory bowel diseases between 1993 and 2003. Acta Gastroenterol Belg 2006 0.83
35 Bronchial eosinophilic infiltration in Crohn's disease in the absence of pulmonary disease. Clin Exp Allergy 1999 0.83
36 Frequently relapsing Crohn's disease is characterized by persistent elevation in interleukin-6 and soluble interleukin-2 receptor serum levels during remission. Int J Colorectal Dis 2000 0.82
37 Incidence of inflammatory bowel disease in the area of Liège: a 3 years prospective study (1993-1996). Acta Gastroenterol Belg 1999 0.81
38 Decreased corticosensitivity in quiescent Crohn's disease: an ex vivo study using whole blood cell cultures. Dig Dis Sci 1999 0.81
39 Evolution and predictive factors of relapse in ulcerative colitis patients treated with mesalazine after a first course of corticosteroids. J Crohns Colitis 2011 0.81
40 [Acute colitis in Wegener's disease: a case report]. Rev Med Liege 2006 0.80
41 Altered expression of type I insulin-like growth factor receptor in Crohn's disease. Clin Exp Immunol 2005 0.80
42 Effect of ranitidine on cobalamin absorption. Dig Dis Sci 1983 0.80
43 Are we giving biologics too much time? When should we stop treatment? World J Gastroenterol 2008 0.79
44 Genetic refinement and physical mapping of a chromosome 16q candidate region for inflammatory bowel disease. Eur J Hum Genet 2001 0.79
45 Adjuvant hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) associated with curative surgery for locally advanced gastric carcinoma. An initial experience. Acta Chir Belg 2006 0.78
46 Barrett's esophagus and its relationship to cancer. J Belge Radiol 1991 0.78
47 Short- and long-term efficacy of cyclosporin administration in patients with acute severe ulcerative colitis. Belgian IBD Group. Acta Gastroenterol Belg 1998 0.78
48 Familial Crohn's disease: a study of 18 families. Acta Gastroenterol Belg 1997 0.78
49 Hepatitis C virus transmission following invasive medical procedures. J Intern Med 1999 0.78
50 Soluble interleukin-2 receptor in Crohn's disease. Assessment of disease activity and prediction of relapse. Dig Dis Sci 1995 0.78
51 Osteoporosis in inflammatory bowel disease: effect of calcium and vitamin D with or without fluoride. Aliment Pharmacol Ther 2002 0.78
52 In vitro effect of duodenal juice on R binders cobalamin complexes in subjects with pancreatic insufficiency: correlation with cobalamin absorption. Gut 1987 0.78
53 Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine. Aliment Pharmacol Ther 2003 0.78
54 [2 fatal cases of yellow fever seen in France and contracted in Senegal (epidemiological and clinical aspects)]. Bull Soc Pathol Exot Filiales 1980 0.78
55 Medical treatment of chronic anal fissure. where do we stand on reversible chemical sphincterotomy? Acta Gastroenterol Belg 2004 0.78
56 Experimental models of inflammatory bowel disease. Acta Gastroenterol Belg 1995 0.77
57 Effect of folate deficiency on vitamin B12 absorption. Ann Nutr Metab 1982 0.77
58 Genetics of Crohn's disease behaviour. Acta Gastroenterol Belg 2001 0.77
59 [Non-specific chronic ulcerous jejuno-ileitis. Presentation of a new case]. Gastroenterol Clin Biol 1977 0.77
60 Treatment of acute diarrhoea: update of guidelines based on a critical interuniversity assessment of medications and current practices. Acta Gastroenterol Belg 2003 0.77
61 [Antineutrophil cytoplasmic antibodies (ANCA) in inflammatory diseases of the digestive tract]. Acta Gastroenterol Belg 1994 0.77
62 [Insulinoma: diagnostic elements. 13 cases]. Presse Med 1985 0.76
63 A patient who survived total colonic ulcerative colitis surinfected by cytomegalovirus complicated by toxic megacolon and disseminated intravascular coagulation. Acta Gastroenterol Belg 2005 0.76
64 [Pseudo-alcoholic hepatitis and cirrhosis caused by amiodarone (Cordarone)]. Rev Med Liege 1998 0.76
65 Incidence of inflammatory bowel disease in the province of Liège (Belgium). La Société de Gastroentérologie Liègeoise. Acta Gastroenterol Belg 1996 0.76
66 [Anatomo-clinical study of a case of regenerative nodular hyperplasia of the liver with Felty's syndrome and portal hypertension]. Ann Anat Pathol (Paris) 1979 0.75
67 Letter: should immunosuppressive therapy be started with adalimumab in Crohn's disease? Authors' reply. Aliment Pharmacol Ther 2013 0.75
68 A naturalistic study of the determinants of health related quality of life improvement in osteoarthritic patients treated with non-specific non-steroidal anti-inflammatory drugs. Ann Rheum Dis 2004 0.75
69 Effect of chronic ranitidine treatment on secretion of intrinsic factor. Br Med J (Clin Res Ed) 1982 0.75
70 [Genomics of inflammatory bowel diseases: basis for a new molecular classification and new therapeutic strategies of these diseases]. Rev Med Liege 2009 0.75
71 Increased response of blood eosinophils to various chemotactic agents in quiescent Crohn disease. Scand J Gastroenterol 2001 0.75
72 [Nodular regenerative hyperplasia of the liver with portal hypertension associated with Felty's syndrome. Report of a case (author's transl)]. Gastroenterol Clin Biol 1978 0.75
73 [Guidelines for the management of Helicobacter pylori: recent opinion of the French National Society of Gastroenterology]. Rev Med Liege 2000 0.75
74 [Serum lysozyme in ulcerative colitis and Crohn's disease]. Arch Fr Mal App Dig 1976 0.75
75 [Intestinal lymphangiectasia associated with fibrosis of mesenteric nodes (author's transl)]. Gastroenterol Clin Biol 1980 0.75
76 [Gastro-enterology in 1981]. Rev Prat 1981 0.75
77 Hepatitis C of genotype 2: the role of medical invasive exams. Acta Gastroenterol Belg 2011 0.75
78 Persisting signs of disease activity at Magnetic Resonance Enterocolonography predict clinical relapse and disease progression in quiescent Crohn's disease. Acta Gastroenterol Belg 2015 0.75
79 [Food intolerance and allergy in the irritable bowel syndrome]. Rev Med Liege 2005 0.75
80 [Monoclonal antibodies therapies for colorectal cancer: cétuximab, panitumumab and bevacizumab]. Rev Med Liege 2009 0.75
81 [Hepatopulmonary syndrome]. Rev Med Liege 1997 0.75
82 [Acute transitory colitis associated with taking ampicillin]. Gastroenterol Clin Biol 1979 0.75
83 Extensive ulcerative colitis and extraintestinal manifestations in a patient with HIV infection and significant CD4 T-cell lymphopenia. Gastroenterol Clin Biol 1997 0.75
84 [Vaccination against hepatitis A and B]. Rev Med Liege 1997 0.75
85 [Gamma-heavy chain disease with autoimmune abnormalities and peripheral neuropathy (author's transl)]. Ann Med Interne (Paris) 1980 0.75
86 [Gastrointestinal complications of diabetes]. Rev Med Liege 1989 0.75
87 Letter: Hyperthyrocalcitoninaemia, Schwartz-Bartter syndrome, and oat-cell carcinoma. Lancet 1974 0.75
88 [Treatment of (unresectable) hepatocellular carcinoma at an intermediate or advanced stage]. Rev Med Liege 2009 0.75
89 [Edemas with hypernatremia. Mechanism and treatment (author's transl)]. Sem Hop 1980 0.75
90 [Collagenous colitis, achlorhydric gastritis and IgG deficiency]. Rev Med Liege 1990 0.75
91 Decrease in systemic tolerance to fed ovalbumin in indomethacin-treated mice. Int Arch Allergy Immunol 1996 0.75
92 [Corticosteroid sensitivity, dependence and resistance in inflammatory and immunologic diseases. Physiopathologic review]. Rev Med Liege 1998 0.75
93 [The FibroScan: a new non invasive method of liver fibrosis evaluation]. Rev Med Liege 2007 0.75
94 [Fifteen years of use of anti-TNF antibodies in moderate to severe Crohn's disease: how to make the best of this experience]. Rev Med Liege 2012 0.75
95 Depth of remission in Crohn's disease patients seen in a referral centre : associated factors and impact on disease outcome. Acta Gastroenterol Belg 2014 0.75
96 [Controversies in the treatment of Helicobacter pylori]. Rev Med Liege 1999 0.75
97 [Endoscopic mucosa resection for superficial esophageal carcinoma: an alternative to radical surgery?]. Rev Med Liege 2005 0.75
98 [Genetics and environment in chronic inflammatory bowel diseases]. Rev Med Liege 2012 0.75
99 [How I treat ... ascites]. Rev Med Liege 2001 0.75
100 Immune deficiency and primary biliary cirrhosis. Gastroenterology 1987 0.75
101 [Renal disorders in cirrhotic patients: functional renal failure and metabolic acidosis (author's transl)]. Sem Hop 1981 0.75
102 [Gitelman syndrome: a rare cause of hypokalemia]. Rev Med Liege 2000 0.75
103 Acute liver failure. Diagnosis, management and results after orthotopic liver transplantation. Acta Chir Belg 1995 0.75
104 [Clinical case of the month. Hereditary hemochromatosis]. Rev Med Liege 1996 0.75
105 [Biologic therapies in chronic inflammatory bowel diseases]. Rev Med Liege 2009 0.75
106 Intestinal permeability in Crohn's disease. Acta Gastroenterol Belg 1996 0.75
107 [Hypercalcemia in patients with primary carcinoma of the liver without bone metastases (author's transl)]. Arch Fr Mal App Dig 1975 0.75
108 [Small cell bronchial cancer, Schwartz-Bartter syndrome and hyperthyrocalcitonemia. Apropos of 2 cases]. Nouv Presse Med 1974 0.75
109 [Acute hepatic insufficiency. Diagnosis, treatment and results following orthotopic liver transplantation]. Rev Med Liege 1993 0.75
110 [Diuretic-induced acute hyponatremia in a hypertensive patient without edemas (author's transl)]. Schweiz Rundsch Med Prax 1978 0.75
111 The deoxyuridine suppression test in macrocytosis of chronic alcoholism. Am J Clin Nutr 1978 0.75
112 [Video-capsule endoscopy for small bowel investigation]. Rev Med Liege 2004 0.75
113 [Comparison of the efficacy of laparoscopy and puncture biopsy with a Menghini needle in the diagnosis of cirrhosis of the liver]. Sem Hop 1976 0.75
114 [Immune deficiency, sarcoidosis and primary biliary cirrhosis]. Gastroenterol Clin Biol 1986 0.75
115 [Physiological inflammatory state of the digestive mucous membrane]. Rev Med Liege 1990 0.75
116 [Current contribution of genetics in intestinal inflammatory diseases]. Acta Clin Belg 1993 0.75
117 [Eosinophilic esophagitis in adults: report of a case]. Rev Med Liege 2008 0.75
118 [Hypocalcemia and intestinal bypass for obesity (author's transl)]. Nouv Presse Med 1979 0.75
119 [Therapeutic alternatives in Crohn disease and in ulcero-hemorrhagic rectocolitis: current findings]. Rev Med Liege 1992 0.75
120 [Echo-endoscopy: a new technic in the study of the digestive tract]. Rev Med Liege 1990 0.75
121 [Ménétrier's disease with protein and calcium loss (author's transl)]. Arch Fr Mal App Dig 1977 0.75
122 Pregnancy and inflammatory bowel disease. Acta Gastroenterol Belg 2003 0.75
123 "Folate-losing gastropathy" and intestinal folate absorption in patients with Ménétrier's disease (giant hypertrophic gastritis). Am J Dig Dis 1978 0.75
124 [Gastroesophageal reflux in the adult: diagnosis and treatment]. Rev Med Liege 2000 0.75
125 [Polyarteritis nodosa related to hepatitis b virus infection]. Rev Med Liege 1999 0.75
126 Determinants of gastro-protective drugs co-prescription during treatment with nonselective NSAIDs: a prospective survey of 2197 patients recruited in primary care. Osteoarthritis Cartilage 2006 0.75
127 Systemic immune response after rectocolonic administration of ovalbumin in mice. Int Arch Allergy Immunol 1995 0.75
128 [Prostate cancer and disseminated intravascular blood coagulation]. Sem Hop 1973 0.75
129 [Chronic diarrhea and the Holmes-Adie syndrome]. Gastroenterol Clin Biol 1980 0.75
130 [Metabolic acidosis and alcoholic cirrhosis--respective role of the kidney and of the chloride ion (author's transl)]. Schweiz Rundsch Med Prax 1981 0.75
131 [Abdominal lymph node tuberculosis: diagnostic value of echography and x-ray computed tomography]. Gastroenterol Clin Biol 1986 0.75
132 Treatment of inflammatory bowel disease with azathioprine: how to use it in 1999. Acta Gastroenterol Belg 2000 0.75
133 [Screening for colorectal cancer]. Rev Med Liege 2007 0.75
134 [Current immunological aspects of Crohn's disease]. Rev Med Liege 1991 0.75
135 Chronic ischaemic gastritis: an unusual form of splanchnic vascular insufficiency. J Cardiovasc Surg (Torino) 1992 0.75
136 [Immunosuppressive treatment and Crohn's disease]. Rev Med Liege 1991 0.75
137 [Adenocarcinoma of the small intestines complicating coeliac disease in an adult: case report]. Rev Med Liege 2009 0.75
138 [Digestive immune system and neuroendocrine peptides]. Rev Med Liege 1990 0.75
139 [Hypercalcemia in cancer of the esophagus]. Nouv Presse Med 1977 0.75
140 Book Reviews. Acta Clin Belg 1989 0.75
141 [Macrocytosis in chronic alcoholism: a disturbance of DNA synthesis related to folate deficiency? (author's transl)]. Gastroenterol Clin Biol 1978 0.75
142 [Hepatitis E: a Third World's hepatitis found in Belgium]. Rev Med Liege 2008 0.75
143 Should patients under long-term anti-TNF therapies be followed for tuberculosis contamination? Inflamm Bowel Dis 2010 0.75
144 [Methods of hepatitis C virus transmission]. Rev Med Liege 1997 0.75
145 [Chronic anemia in inflammatory bowel diseases: review]. Rev Med Liege 2005 0.75
146 [Colorectal cancer screening: an absolute necessity and a concrete reality in the French community]. Rev Med Liege 2009 0.75
147 [Heat stroke with anuria, muscular disorders and early hypercalcemia]. Nouv Presse Med 1977 0.75
148 [Subacute myelo-optic-neuropathy during treatment with chloro-iodo-hydroxyquinoleine (author's transl)]. Gastroenterol Clin Biol 1979 0.75
149 [Primary and secondary prevention of colorectal cancer]. Rev Med Liege 2003 0.75
150 Book Review. Acta Clin Belg 1990 0.75
151 [Gastro-esophageal reflux and asthma]. Rev Med Liege 1999 0.75
152 [Physiology of enterochromaffin-like cells in the regulation of gastric acid secretion]. Rev Med Liege 1992 0.75
153 [Sphincterotomy and ablation of choledochal calculi by endoscopy. Apropos of 14 cases]. Ann Med Interne (Paris) 1977 0.75
154 Letter: Serum lysozyme in inflammatory bowel disease. Gastroenterology 1976 0.75
155 Genetics and inflammatory bowel disease: from association studies to wide genome screen. Acta Gastroenterol Belg 1998 0.75
156 [FROM EVIDENCE-BASED MEDICINE TO PERSONALIZED MEDICINE IN CROHN'S DISEASE]. Rev Med Liege 2015 0.75
157 [Atypical development of chronic hepatitis B: role of the B virus mutant. Apropos of a case]. Rev Med Liege 1992 0.75